{
  "url": "https://openlegislation.uk/council-of-the-pharmaceutical-society-of-northern-ireland-continuing-professional-development-regulations-northern-ireland-2012/regulation-26",
  "json_url": "https://openlegislation.uk/council-of-the-pharmaceutical-society-of-northern-ireland-continuing-professional-development-regulations-northern-ireland-2012/regulation-26.json",
  "legislation": "nisr/2012/312",
  "legislation_title": "The Council of the Pharmaceutical Society of Northern Ireland (Continuing Professional Development) Regulations (Northern Ireland) 2012",
  "legislation_url": "https://openlegislation.uk/council-of-the-pharmaceutical-society-of-northern-ireland-continuing-professional-development-regulations-northern-ireland-2012",
  "path": "regulation/26",
  "kind": "regulation",
  "number": "26",
  "heading": "Postponements and adjournments",
  "text": "(1) The chair may, of the chair’s own motion, or upon the application of a party, postpone any hearing of which notice has been given under these regulations before the hearing begins.\n(2) The Statutory Committee may, of its own motion, or upon the application of a party, adjourn the proceedings at any stage, provided that—\n(a) no injustice is caused to the parties; and\n(b) the decision to adjourn is made after hearing representations from the parties (where present).\n(3) In considering whether or not to grant a request for postponement or adjournment, the chair or Statutory Committee must, in particular, have regard to—\n(a) the public interest in the expeditious disposal of the case;\n(b) the potential inconvenience caused to a party or any witnesses to be called by a party;\n(c) the conduct of the party seeking the postponement or adjournment; and\n(d) fairness to the parties.\n(4) Where the proceedings have been postponed or adjourned, the secretary must, as soon as practicable, notify the parties of the date, time and venue of the re-listed or resumed hearing.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Regs. 12-29 inserted (31.5.2013) by The Council of the Pharmaceutical Society of Northern Ireland (Continuing Professional Development) (Amendment) Regulations (Northern Ireland) 2013 (S.R. 2013/147), regs. 1(1), 9"
    },
    {
      "type": "C",
      "label": "C1",
      "text": "Regs. 14-29 applied (1.6.2014) by The Council of the Pharmacetical Society of Northern Ireland (Indemnity Arrangements) Regulations (Northern Ireland) 2014 (S.R. 2014/126), regs. 1(1), 10"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/nisr/2012/312/regulation/26",
    "retrieved_at": "2026-10-29T01:14:23.545536+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}